This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Kayne Anderson MLP Investment Company Announces Public Offering Of Common Stock

Kayne Anderson MLP Investment Company (the “Company”) (NYSE: KYN) announced that it has commenced a public offering of 5,000,000 shares of its common stock. The Company also intends to grant the underwriters a 45-day option to purchase up to 750,000 additional common shares to cover over-allotments, if any. Net proceeds from the offering will be used to make additional portfolio investments that are consistent with the Company’s investment objective and policies and for general corporate purposes.

Citigroup, BofA Merrill Lynch, Morgan Stanley, UBS Investment Bank and Wells Fargo Securities are acting as joint book-running managers. A copy of the preliminary prospectus supplement and the base prospectus relating to the offering may be obtained from the following addresses:
Citigroup  

BofA Merrill Lynch
Attn: Prospectus Department

Attn: Prospectus Department
Brooklyn Army Terminal

222 Broadway, 7th Floor
140 58th Street, 8th Floor

New York, NY 10038
Brooklyn, NY 11220

Email: dg.prospectus_requests@baml.com
Telephone: 800-831-9146

Email: batprospectusdept@citi.com
 
Morgan Stanley

UBS Investment Bank
Attn: Prospectus Department

Attn: Prospectus Department
180 Varick Street, 2nd Floor

299 Park Avenue
New York, NY 10014

New York, NY 10171

Email: prospectus@morganstanley.com

Telephone: 888-827-7275
Telephone: 866-718-1649
 
Wells Fargo Securities
Attention: Equity Syndicate Dept.
375 Park Ave
New York, NY 10152
Telephone: 800-326-5897

Email: cmclientsupport@wellsfargo.com
 

Investors may also obtain these documents free of charge from the Company’s website at www.kaynefunds.com/kyn/sec-filings/ or the Securities and Exchange Commission’s (“SEC”) website at www.sec.gov.

An investor should read the Company’s preliminary prospectus supplement and the base prospectus carefully before investing. The preliminary prospectus supplement and the base prospectus contain important information about the Company and its investment objective and policies, risks, charges and expenses.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.91 +93.33 0.53%
S&P 500 2,081.34 +12.58 0.61%
NASDAQ 4,997.4590 +5.5190 0.11%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs